You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid

Article info

Article menu
Short report
Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid

Authors

  • Francisco J. Meda Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • Kathryn Knowles Dementia Research Center, Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, London, UKUK Dementia Research Institute at University College London, London, UK PubMed articlesGoogle scholar articles
  • Imogen J. Swift Dementia Research Center, Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, London, UKUK Dementia Research Institute at University College London, London, UK PubMed articlesGoogle scholar articles
  • Aitana Sogorb-Esteve Dementia Research Center, Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, London, UKUK Dementia Research Institute at University College London, London, UK PubMed articlesGoogle scholar articles
  • Jonathan D. Rohrer Dementia Research Center, Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, London, UK PubMed articlesGoogle scholar articles
  • Anna Dittrich Neuropsychiatric Epidemiology Unit, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, SwedenDepartment of Psychiatry Cognition and Old Age Psychiatry, Sahlgrenska University Hospital, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • Ingmar Skoog Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, SwedenDepartment of Psychiatry Cognition and Old Age Psychiatry, Sahlgrenska University Hospital, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • Silke Kern Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, SwedenNeuropsychiatric Epidemiology Unit, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Bruno Becker Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • Kaj Blennow Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, SwedenClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • Ulf Andreasson Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, SwedenClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • Hlin Kvartsberg Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, SwedenClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • Henrik Zetterberg Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, SwedenClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Francisco J. Meda; francisco.meda{at}gu.se
View Full Text

Citation

Meda FJ, Knowles K, Swift IJ, et al
Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid
BMJ Neurology Open 2023;5:e000395. doi: 10.1136/bmjno-2022-000395

Publication history

  • Accepted February 11, 2023
  • First published February 27, 2023.
Online issue publication 
February 27, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.